Article ; Online: Effects of cyclopiazonic acid and dexamethasone on serotonin-induced calcium responses in vascular smooth muscle cells.
Journal of physiology and biochemistry
2016 Volume 72, Issue 2, Page(s) 245–253
Abstract: We previously observed that sarcoendoplasmic reticulum Ca(2+) ATPase (SERCA) blockade by cyclopiazonic acid (CPA) significantly potentiates serotonin (5-hydroxytryptamine (5-HT))-induced vascular contractions. Furthermore, 5-HT receptor antagonist ... ...
Abstract | We previously observed that sarcoendoplasmic reticulum Ca(2+) ATPase (SERCA) blockade by cyclopiazonic acid (CPA) significantly potentiates serotonin (5-hydroxytryptamine (5-HT))-induced vascular contractions. Furthermore, 5-HT receptor antagonist methysergide partially inhibited CPA-potentiated 5-HT contractions. In the present study, we further investigated whether SERCA inhibition potentiates 5-HT-induced Ca(2+) responses along with attenuating the receptor antagonism by store-operated Ca(2+) (SOC) entry and protein kinase C (PKC)-mediated mechanisms. The effects of dexamethasone that was previously shown to induce SOC entry and enhance 5-HT responses were also tested. For this purpose, intracellular Ca(2+) levels were monitored in A7r5 embryonic rat vascular smooth muscle cells by spectrofluorometry using the fluorescent indicator fura-2. The results showed that CPA, although not dexamethasone, significantly potentiated 5-HT-induced Ca(2+) elevations. Ketanserin partially decreased 5-HT-induced and CPA-potentiated Ca(2+) elevations whereas both PKC inhibitor D-sphingosine and SOC entry blocker 2-aminoethoxydiphenyl borate (2-APB) abolished the remaining responses. The data suggests that diminished antagonistic effect on 5-HT-induced Ca(2+) elevations in the presence of SERCA inhibition is induced by SOC entry and PKC activation. |
---|---|
MeSH term(s) | Animals ; Anti-Inflammatory Agents/chemistry ; Anti-Inflammatory Agents/pharmacology ; Calcium Channel Blockers/pharmacology ; Calcium Signaling/drug effects ; Cell Line ; Dexamethasone/antagonists & inhibitors ; Dexamethasone/pharmacology ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Indoles/antagonists & inhibitors ; Indoles/pharmacology ; Ketanserin/pharmacology ; Methysergide/pharmacology ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/metabolism ; Protein Kinase C/antagonists & inhibitors ; Protein Kinase C/metabolism ; Protein Kinase Inhibitors/pharmacology ; Rats ; Sarcoplasmic Reticulum Calcium-Transporting ATPases/antagonists & inhibitors ; Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism ; Serotonin/chemistry ; Serotonin/metabolism ; Serotonin Antagonists/pharmacology ; Serotonin Receptor Agonists/chemistry ; Serotonin Receptor Agonists/pharmacology ; Vasoconstrictor Agents/antagonists & inhibitors ; Vasoconstrictor Agents/pharmacology ; Vasodilator Agents/antagonists & inhibitors ; Vasodilator Agents/pharmacology |
Chemical Substances | Anti-Inflammatory Agents ; Calcium Channel Blockers ; Enzyme Inhibitors ; Indoles ; Protein Kinase Inhibitors ; Serotonin Antagonists ; Serotonin Receptor Agonists ; Vasoconstrictor Agents ; Vasodilator Agents ; Serotonin (333DO1RDJY) ; Dexamethasone (7S5I7G3JQL) ; Ketanserin (97F9DE4CT4) ; Protein Kinase C (EC 2.7.11.13) ; Sarcoplasmic Reticulum Calcium-Transporting ATPases (EC 3.6.3.8) ; cyclopiazonic acid (X9TLY4580Z) ; Methysergide (XZA9HY6Z98) |
Language | English |
Publishing date | 2016-06 |
Publishing country | Spain |
Document type | Comparative Study ; Journal Article |
ZDB-ID | 1325104-1 |
ISSN | 1877-8755 ; 0034-9402 ; 1138-7548 |
ISSN (online) | 1877-8755 |
ISSN | 0034-9402 ; 1138-7548 |
DOI | 10.1007/s13105-016-0474-8 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 198: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.